Atlas Trials

Booster Study of SpikoGen COVID-19 Vaccine

Clinical trial NCT05542862 · COMPLETED

Trial details

NCT number
NCT05542862
Sponsor
Vaxine Pty Ltd
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
COVID-19
Start date
2022-09-07
Primary completion
2023-12-31
Enrollment
81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.